Chemodex

D-Sphingosine

CHF 103.00
In stock
CDX-D0559-M02525 mgCHF 103.00
More Information
Product Details
Synonyms (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol; D-erythro-Sphingosine C-18; (-)-Sphingosine
Product Type Chemical
Properties
Formula

C18H37NO2

MW 299.49
CAS 123-78-4
Source/Host Chemicals Synthetic
Purity Chemicals ≥ 97% (TLC)
Appearance White powder.
Solubility Soluble in ethanol, DMSO, methanol or chloroform (10mg/ml). Insoluble in water.
Identity Determined by 11H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key WWUZIQQURGPMPG-KRWOKUGFSA-N
Smiles OC[C@@](N)([H])[C@]([H])(O)/C=C/CCCCCCCCCCCCC
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

D-Sphingosine is a characteristic structural unit of many sphingolipids such as ceramides, gangliosides, globosides, sulfatides, sphingomyelin, and others. It is most abundant in nervous tissue and cell membranes. Sphingosine with an 18-carbon chain and a double bond at carbon 4 is the most abundant sphingosine in animal tissues. D-Sphingosine inhibits protein kinase C and phosphatidic acid phosphohydrolase, whereas it activates phospholipase D, diacylglycerol (DAG) kinase and the cation channel TRPM3. Phosphorylation of sphingosine by sphingosine kinases 1 and 2 (SPHK 1, SPHK 2) produces sphingosine-1-phosphate, a potent bioactive lipid that exhibits a broad spectrum of biological activities including cell proliferation, survival, migration, cytoskeletal organization and morphogenesis.

Product References

(1) W.A. Khan, et al.; BBRC 172, 683 (1990) | (2) W.A. Khan, et al.; Biochem. J. 278, 387 (1991) | (3) Y.A. Hannun, et al.; Biochemistry 40, 4893 (2001) | (4) Y. Takuwa, et al.; J. Biochem. 131, 767 (2002) | (5) M.J. Kluk & T. Hla; Biochim. Biophys. Acta 1582, 72 (2002) | (6) I. Ishii, et al.; Annu. Rev. Biochem. 73, 321 (2004) | (7) H. Nakamura, et al.; Eur. J. Pharmacol. 484, 9 (2004) | (8) C. Grimm, et al.; Mol. Pharmacol. 67, 798 (2005) | (9) V.T. Pham, et al.; Arch. Pharm. Res. 30, 22 (2007) | (10) K. Held, et al.; Temperature 2, 201 (2015)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.